Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Telemedycyna PolskaWAR:TMP +1.56%28 Days Payable is 327.95 as of Mar. 2026, which is 15% above its 10-year median of 284.14. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Telemedycyna Polska ranks better than 93.07% on this metric.
The historical rank and industry rank for Telemedycyna Polska's Days Payable or its related term are showing as below:
WAR:TMP'
s Days Payable Range Over the Past 10 Years
Min: 109.03 Med: 284.14 Max: 1204.25
Current: 471.01
During the past 13 years, Telemedycyna Polska's highest Days Payable was 1204.25. The lowest was 109.03. And the median was 284.14.
WAR:TMP's Days Payable is ranked better than 93.07% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.015
vs WAR:TMP: 471.01
Telemedycyna Polska's Days Payable
declined
from Mar. 2025 (365.68) to Mar. 2026 (327.95).
It may suggest that Telemedycyna Polskaaccelerated paying its suppliers.
The historical data trend for Telemedycyna Polska's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:TMP vs VEEV, BTSG, HQY: Days Payable Comparison
For the Health Information Services subindustry, Telemedycyna Polska's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telemedycyna Polska Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's Days Payable distribution charts can be found below:
* The bar in red indicates where Telemedycyna Polska's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Telemedycyna Polska's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telemedycyna Polska (WAR:TMP) has a Days Payable of 327.95 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Telemedycyna Polska and its competitors. This is 15% above median its historical median of 284.14. Over the past decade, Telemedycyna Polska's Days Payable has ranged from 109.03 to 1,204.25. According to the industry distribution chart, Telemedycyna Polska ranks #42 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 6.9%.
Is Telemedycyna Polska's Days Payable too high?
Telemedycyna Polska's current Days Payable of 327.95 is 15% above median its 10-year median of 284.14. Over the past 10 years, this metric has ranged from a low of 109.03 to a high of 1,204.25. The Healthcare Providers & Services industry median Days Payable is 57.02. Telemedycyna Polska's value of 327.95 is 475.2% above this industry median. Based on the distribution chart, Telemedycyna Polska ranks #42 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #42 out of 606 companies for Days Payable. This places Telemedycyna Polska in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.02. Telemedycyna Polska's value of 327.95 is 475.2% above this benchmark. Historically, Telemedycyna Polska's own Days Payable has ranged from 109.03 to 1,204.25 over the past decade. While the company's 10-year median is 284.14 vs. the industry median of 57.02, Telemedycyna Polska has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.02, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telemedycyna Polska's current Days Payable of 327.95 is 475.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Telemedycyna Polska and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telemedycyna Polska's current Days Payable is 327.95, which is 15% above median its own 10-year median of 284.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current Days Payable is 327.95, which is 15% above median its 10-year median of 284.14 and 475.2% above the Healthcare Providers & Services industry median of 57.02. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current Days Payable is 327.95 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?
Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued.
The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82.
GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.
Key valuation signals for WAR:TMP:
Days Payable: 327.95 (15% above median its 10-year median of 284.14)
GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
Industry Position: 475.2% above the Healthcare Providers & Services median (#42 of 606)
No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score
Get the complete analysis for WAR:TMP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:TMP has been successfully added to your 
